CRM197 protein market is entering a dynamic growth phase driven by rising vaccine innovation, expanding immunization programs, and advancements in protein engineering. Latest industry insights indicate the market will grow from USD 174 million in 2024 to USD 246 million by 2031, expanding at a CAGR of 5.2%. This surge reflects the essential role of CRM197 in conjugate vaccine development,...